Evolent Health, Inc. has announced its financial results for the third quarter of 2026, demonstrating significant revenue growth and a commitment to enhancing health outcomes for patients with complex conditions. The company reported that its innovative solutions and strong execution in oncology launches have contributed to its positive performance.
On November 5, 2026, Evolent issued a press release detailing its financial results for the quarter ended September 30, 2026. This announcement is significant as it highlights the company's ongoing efforts to improve healthcare affordability and patient experience, which are critical factors in the management services industry.
Background
Evolent Health, Inc., incorporated in Delaware, operates under the Standard Industrial Classification (SIC) code 8741, which pertains to management services. The company is listed on the New York Stock Exchange under the ticker symbol EVH. Evolent focuses on providing solutions that simplify healthcare and improve outcomes for patients with complex conditions.
What the Filing Says
The filing reveals that Evolent's revenue for the third quarter of 2026 reached $725.4 million, a substantial increase compared to $479.5 million in the same quarter of the previous year. The net loss attributable to common shareholders was reported at $23.6 million, which is an improvement from the $26.9 million loss reported in Q3 2025. Seth Blackley, Co-Founder and CEO, stated, "As health plan customers seek to balance affordability with patient and doctor experience, they continue to turn to Evolent by renewing agreements and in many cases, expanding the work they do with us."
Impact
The results may influence various stakeholders, including healthcare providers, patients, and competitors within the management services sector. The positive performance and growth in demand for Evolent's services suggest that the company is effectively meeting the needs of its clients, which may prompt competitors to reassess their strategies.
What's Next
The filing does not say what happens next.
Read Next
Ronald N. Tutor sells 150,000 shares of Tutor Perini Corp.
Generation Income Properties reports Q3 2026 results
Greenlane Holdings reports Q3 2026 results amid challenges
Permianville Royalty Trust Reports Q3 Financial Results
Cue Biopharma Reports Q3 Results with Financial Insights
Atlantica Inc Reports Q3 Results, Highlights Financial Updates










